BELLEVILLE, ON, Nov. 24 /CNW/ - Bioniche Life Sciences Inc. (TSX: BNC - News), a research-based, technology-driven Canadian biopharmaceutical company, presented data about its proprietary Mycobacterial Cell Wall-DNA Complex (MCC) - trademarked Urocidin - to an international audience of urologists at the 2008 Société Internationale d'Urologie (SIU) Congress in Santiago, Chile on Saturday.
